Ocuphire Pharma (OCUP) stock Forecast for 2021 – 2025

Ocuphire Pharma (OCUP) stock Forecast for 2022 – 2026

Last update: 05-21-2022, 7:53

Sector: Healthcare

The share price of Ocuphire Pharma, Inc. (OCUP) now

What analysts predict:: $23.67

52-week high/low: $7 / $1.8

50/200 Day Moving Average: $2.911 / $3.743

This figure corresponds to the average price over the previous 50/200 days. For Ocuphire Pharma stocks, the 50-day moving average is the resistance level today.

For Ocuphire Pharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Ocuphire Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ocuphire Pharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Ocuphire Pharma share be worth in 2022 - 2026?

When should I take profit in Ocuphire Pharma stock? When should I record a loss on Ocuphire Pharma stock? What are analysts' forecasts for Ocuphire Pharma stock? What is the future of Ocuphire Pharma stock?

We forecast Ocuphire Pharma stock performance using neural networks based on historical data on Ocuphire Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Ocuphire Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Ocuphire Pharma shares. This happens once a day.




Historical and forecast chart of Ocuphire Pharma stock

The chart below shows the historical price of Ocuphire Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Ocuphire Pharma stock price can be found in the table below.

Long-term forecasts by years.

Ocuphire Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
May 23 2.14 2.08 2.23 6.89
May 24 2.14 2.10 2.16 2.69
May 25 2.13 2.05 2.20 7.22
May 26 2.07 2.01 2.14 6.49
May 27 2.06 2.01 2.12 5.53
May 28 2.09 2.04 2.13 4.30
May 29 2.05 2.01 2.08 3.21
May 30 2.04 1.97 2.12 7.61
May 31 1.98 1.92 2.03 5.42
Jun 01 1.98 1.90 2.00 5.25
Jun 02 1.99 1.97 2.04 3.84
Jun 03 2.03 2.01 2.09 4.14
Jun 04 2.11 2.05 2.15 5.00
Jun 05 2.09 2.06 2.12 2.74
Jun 06 2.17 2.14 2.21 3.24
Jun 07 2.20 2.16 2.26 4.73
Jun 08 2.26 2.17 2.28 5.25
Jun 09 2.29 2.24 2.34 4.29
Jun 10 2.19 2.12 2.27 6.66
Jun 11 2.21 2.14 2.30 7.61
Jun 12 2.23 2.19 2.25 2.80
Jun 13 2.24 2.21 2.29 3.39
Jun 14 2.31 2.23 2.36 5.69
Jun 15 2.29 2.21 2.37 7.41
Jun 16 2.39 2.29 2.46 7.50
Jun 17 2.36 2.31 2.45 5.99
Jun 18 2.39 2.32 2.47 6.44
Jun 19 2.34 2.28 2.43 6.48
Jun 20 2.31 2.27 2.36 3.97
Jun 21 2.22 2.19 2.24 2.53

Ocuphire Pharma Daily Price Targets


Ocuphire Pharma Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $2.14. Positive dynamics for Ocuphire Pharma shares will prevail with possible volatility of 6.445%.

Pessimistic target level: 2.08

Optimistic target level: 2.23


Ocuphire Pharma Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $2.14. Negative dynamics for Ocuphire Pharma shares will prevail with possible volatility of 2.624%.

Pessimistic target level: 2.10

Optimistic target level: 2.16


Ocuphire Pharma Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $2.13. Negative dynamics for Ocuphire Pharma shares will prevail with possible volatility of 6.731%.

Pessimistic target level: 2.05

Optimistic target level: 2.20


Ocuphire Pharma Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $2.07. Negative dynamics for Ocuphire Pharma shares will prevail with possible volatility of 6.093%.

Pessimistic target level: 2.01

Optimistic target level: 2.14


Ocuphire Pharma Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $2.06. Negative dynamics for Ocuphire Pharma shares will prevail with possible volatility of 5.240%.

Pessimistic target level: 2.01

Optimistic target level: 2.12


Ocuphire Pharma Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $2.09. Positive dynamics for Ocuphire Pharma shares will prevail with possible volatility of 4.124%.

Pessimistic target level: 2.04

Optimistic target level: 2.13


OCUP (OCUP) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 1.95 1.66 2.15 22.90
Jul. 2.06 1.74 2.32 24.89
Aug. 2.20 1.99 2.59 23.19
Sep. 2.14 1.87 2.30 18.79
Oct. 1.92 1.71 2.12 19.64
Nov. 2.30 2.04 2.50 18.43
Dec. 2.02 1.78 2.25 20.81

Ocuphire Pharma forecast for this year


Ocuphire Pharma Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $1.9504. Pessimistic: $1.66. Optimistic: $2.15


Ocuphire Pharma Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $2.06255. Pessimistic: $1.74. Optimistic: $2.32


Ocuphire Pharma Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $2.20177. Pessimistic: $1.99. Optimistic: $2.59


Ocuphire Pharma Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $2.13572. Pessimistic: $1.87. Optimistic: $2.30


Ocuphire Pharma Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $1.91681. Pessimistic: $1.71. Optimistic: $2.12


Ocuphire Pharma Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $2.30496. Pessimistic: $2.04. Optimistic: $2.50


Ocuphire Pharma Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $2.01684. Pessimistic: $1.78. Optimistic: $2.25




Ocuphire Pharma (OCUP) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 1.90 1.57 2.16 27.31
Feb 1.83 1.66 2.01 17.31
Mar 1.39 1.24 1.59 21.83
Apr 1.27 1.17 1.47 20.17
May 1.40 1.30 1.66 21.94
Jun 1.38 1.30 1.55 16.04
Jul 1.57 1.33 1.85 28.15
Aug 1.62 1.34 1.83 26.71
Sep 1.47 1.33 1.59 16.20
Oct 1.54 1.38 1.65 16.08
Nov 1.67 1.36 1.79 24.19
Dec 1.63 1.40 1.90 26.18

Ocuphire Pharma (OCUP) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 1.64 1.36 1.91 28.88
Feb 1.37 1.10 1.50 26.61
Mar 1.32 1.12 1.45 23.01
Apr 1.36 1.19 1.59 25.21
May 1.44 1.17 1.55 24.77
Jun 1.33 1.25 1.55 19.57
Jul 1.55 1.27 1.80 29.61
Aug 1.82 1.63 2.05 20.62
Sep 1.46 1.18 1.65 28.70
Oct 1.34 1.17 1.60 26.72
Nov 1.18 1.00 1.40 28.48
Dec 0.93 0.82 0.98 16.24



Ocuphire Pharma (OCUP) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 1.00 0.92 1.18 21.70
Feb 1.10 1.05 1.19 12.27
Mar 1.15 0.92 1.37 32.99
Apr 1.33 1.12 1.53 26.96
May 1.42 1.20 1.61 25.83
Jun 1.60 1.47 1.89 22.36
Jul 1.66 1.36 1.85 26.29
Aug 1.57 1.36 1.82 25.49
Sep 1.72 1.41 1.87 24.25
Oct 1.39 1.25 1.53 17.95
Nov 1.34 1.17 1.50 22.22
Dec 1.44 1.30 1.58 17.81

Ocuphire Pharma (OCUP) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 1.48 1.30 1.56 16.59
Feb 1.40 1.16 1.54 25.11
Mar 1.71 1.57 1.98 20.73
Apr 1.69 1.57 2.00 21.52
May 1.69 1.44 1.95 26.19
Jun 1.75 1.66 2.02 17.75
Jul 1.73 1.50 2.03 26.07
Aug 2.02 1.63 2.16 24.77
Sep 2.16 1.87 2.40 21.85
Oct 2.34 2.22 2.74 18.84
Nov 2.16 1.94 2.34 17.13
Dec 1.79 1.57 1.94 18.75

Ocuphire Pharma information and performance

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.

Ocuphire Pharma Address

15245 SHADY GROVE ROAD, SUITE 455, ROCKVILLE, MD, US

Market Capitalization: 41 052 500 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.817

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 31.55

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 19364400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A


Ocuphire Pharma (OCUP) stock dividend

Ocuphire Pharma last paid dividends on 01/01/1970. The next scheduled payment will be on 11/06/2020. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.